Ensino e Terapia de Inovacao Clinica AMO Etica

Salvador 41950-640

4 studies enrolling now · 6 studies all time

What they study most

Advanced Solid Tumor, B-cell Lymphoma, B-cell Malignancy, Carcinoma, Squamous Cell, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Receptors, Fibroblast Growth Factor, Refractory Cancer, Relapsed Cancer, Relapsed/Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, Urothelial Cancer

Studies at this site

• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC — Recruiting now
• A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies — Recruiting now
• An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed